Biogen Inc
NASDAQ: BIIB
$143.68
-$7.03 (-4.7%)
Real Time Data Delayed 15 Min.
BIIB Articles
Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies were notified of a confirmed case of progressive multifocal...
Published:
Last Updated:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to...
Published:
These are some of the top pre-market upgrades from analysts which we have seen in the early hours this Monday morning: Acorda Therapeutics (ACOR) Raised to Outperform at Baird. Biogen Idec (BIIB)...
Published:
Biogen Idec Inc. (NASDAQ: BIIB has notified regulatory agencies of a confirmed case of progressive multifocal leukoencephalopathy (PML) in a multiple sclerosis patient treated with TYSABRI .
Published:
Last Updated:
Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning: Biogen Idec (BIIB) Raised to Buy at Lazard. Cowen (COWN) Raised to Outperform at KBW. Mylan Labs...
Published:
These are some of the early bird analyst upgrades and positive calls we are seeing this Thursday morning with more than two hours to the open: Auxilium Pharma (AUXL) Started as Outperform at...
Published:
Icahn Enterprises LP (NYSE: IEP) is perhaps known more for its billionaire owner/founder Carl Icahn more than it is for its staff, team efforts, and even the enterprise’s name. Icahn’s...
Published:
Last Updated:
These are some of the key analyst downgrades and negative analyst calls we have seen early this Monday morning with over 2 hours to open: Biogen Idec (BIIB) Cut to Sell at Banc of America. Cbeyond...
Published:
Carl Icahn has evolved over the years, first rising to fame a "corporate raider", followed by an ill-fated journey into actual management at the helm of TWA and, most recently, as a kinder, gentler...
Published:
Last Updated:
Elan Corporation (ELN) Problems with one of the company’s major drugs. Falls to $9.55 from 52-week high of $37.45. Gatehouse (GHS) More poor newspaper earnings raise issue of whether company is...
Published:
Last Updated:
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We do not want to try to sound as though this TYSABRI news is something that...
Published:
Last Updated:
Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23 Billion in revenues according to...
Published:
There was interesting event in a 13D filing today right after the close, and that will be worth some news and gossip alike. An investment firm called Amalgamated Gadget LP, which is roughly a 6.6%...
Published:
Last Updated:
Carl Icahn is a billionaire financier, activist, and investor. Most think of Icahn as an activist investor that wants to get inside and drive value without having to acquire the whole company...
Published:
Last Updated:
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have announced that a Phase II/III study of Rituxan for...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.